Skip to content

Deal · Acquisition29 September 2026 · Announced

Terumo Neuro agrees to acquire clinical-stage biomaterials company Arsenal Medical

Arsenal develops NeoCast, an investigational liquid embolic for chronic subdural hematoma that would join Terumo Neuro's neurovascular portfolio.

Terumo Neuro Acquirer · Arsenal Medical Target

Intelligence

The deal

Type
Acquisition
Amount
Not disclosed
Status
Announced
Valuation
Not recorded
Region
United States
Date
29 September 2026

As of this development: a later development may record new terms.

Lifecycle

  1. Announced29 September 2026 · This development
  2. ClosedNot recorded

The parties

Arsenal Medical Target

1 development · 1 deal in Minutes

Terumo Neuro Acquirer

1 development · 1 deal in Minutes

Activity

More in Healthcare

Past 3 months in Activity →